Selection of MDM2-binding peptides in Escherichia coli using an engineered split intein and aminoglycoside phosphotransferase
Chemical Communications · 2025
DOI: 10.1039/d4cc06138a ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Communications, 2025. Verfasst von Yutaro Watanabe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Science and Technology, Gunma University, 1-5-1 Tenjin-cho, Kiryu, Gunma 376-8515, Japan. ttakahas@gunma-u.ac.jp. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Escherichia coli, Inteins, Kanamycin Kinase. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
A protein trans -splicing (PTS)-based method for screening the peptides capable of binding to a target protein was developed using an engineered split intein and an aminoglycoside phosphotransferase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate School of Science and Technology, Gunma University, 1-5-1 Tenjin-cho, Kiryu, Gunma 376-8515, Japan. ttakahas@gunma-u.ac.jp.
- Department of Science and Technology, Gunma University, 1-5-1 Tenjin-cho, Kiryu, Gunma 376-8515, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Watanabe, Y., Tezuka, C., Nobusawa, K., & Takahashi, T. (2025). Selection of MDM2-binding peptides in Escherichia coli using an engineered split intein and aminoglycoside phosphotransferase. Chemical Communications. https://doi.org/10.1039/d4cc06138a
Vancouver
Watanabe Y, Tezuka C, Nobusawa K, Takahashi T. Selection of MDM2-binding peptides in Escherichia coli using an engineered split intein and aminoglycoside phosphotransferase. Chemical Communications. 2025. doi:10.1039/d4cc06138a
BibTeX
@article{Watanabe2025,
author = {Watanabe, Yutaro and Tezuka, Chiori and Nobusawa, Kana and Takahashi, Tsuyoshi},
title = {Selection of MDM2-binding peptides in Escherichia coli using an engineered split intein and aminoglycoside phosphotransferase},
journal = {Chemical Communications},
year = {2025},
doi = {10.1039/d4cc06138a}
}
EUVIMED